4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-034537
VP Clinical Reg Affairs bought 250 shares at $13.98 ($3,495)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2022-12-02 | Purchase | +250 | $13.98 | $3,495 | 256,245 | D |
| Open-market purchases · 250 sh · avg $13.98 · $3,495 | |||||||
Loading xslF345X03/ownership.xml…